Hypnite (Eszopiclone)

Hypnite (Eszopiclone) – Patient Information for Australia

Basic Product Information

Mechanism of Action

In simple terms: Hypnite contains eszopiclone, a medicine that helps you fall asleep by calming the brain. It belongs to a group of drugs called “Z-drugs,” used to manage insomnia. Eszopiclone boosts the effects of a natural brain chemical, gamma-aminobutyric acid (GABA), making you feel sleepy and helping you stay asleep.

For specialists: Eszopiclone is a cyclopyrrolone hypnotic that selectively binds to GABA_A receptors at the benzodiazepine site, enhancing chloride ion influx, leading to neuronal hyperpolarisation and sedation. It differs structurally from benzodiazepines but shares a similar pharmacodynamic profile.

Pharmacokinetics

• Absorption: Rapid absorption after oral administration—peak plasma levels reached within 1 hour.
• Metabolism: Primarily metabolised in the liver by CYP3A4 and CYP2E1 enzymes.
• Elimination: Excreted mainly in urine (<10% as unchanged drug), with metabolites cleared renally.
• Duration of action: Elimination half-life is about 6 hours—provides a full night of sleep but usually avoids “hangover” sedation when taken as directed.

Everyday Use and Best Practices in Australia

• Intended Use: Short-term treatment of adults with insomnia, particularly for those having difficulty falling asleep, frequent awakenings, or early morning waking.
• Typical Doses: Usually 2 mg taken at bedtime, adjusted to 1 mg for the elderly or those with liver impairment. Some may require 3 mg, but no more than this is recommended.
• How to Take: Take one tablet just before bedtime. Only take if you are able to get a full night’s sleep (7–8 hours).
• Duration: Use for as short a time as possible — often 2–4 weeks, with regular clinical review.
• Repeat Prescriptions: Ongoing use should be assessed by your doctor. Hypnite is not intended for long-term daily use.

Dosing: Morning vs Evening

• Evening Use: Hypnite is only for nightly use. Taking it in the morning can cause drowsiness, poor concentration, or impaired driving for the rest of the day.
• Consistency: Take at the same time each evening before bed to support a healthy sleep pattern and reduce the risk of forgetting or misuse.
• Tip: Set an alarm or reminder around bedtime on your mobile device.

Taking with Food or on an Empty Stomach

• Hypnite can be taken with or without food.
• High-fat meals: Heavy evening meals, such as fish and chips or roast dinners, may slow absorption and delay onset of drowsiness.
• Recommendation: For fastest action, take on an empty stomach or wait at least 2 hours after eating.
• English Diet Context: As Australians often have lighter evening meals, this rarely causes problems.

Interaction Warnings

Indications (Approved and Off-Label)

Dosing According to Clinical Indication

Safety Profile and Side Effects

• Common: Metallic or bitter taste in mouth, headache, dry mouth, drowsiness, dizziness, cold-like symptoms
• Less Common: Flu-like symptoms, nausea, irritation of nose/throat, abnormal dreams
• Rare but Serious: Sleepwalking or other unusual sleep behaviours (eating, driving while asleep); signs of allergic reaction (swelling, rash, difficulty breathing); confusion or agitation, particularly in older adults
• Warnings: Prolonged use may lead to dependence or withdrawal symptoms. Not recommended for those with a history of addiction or sleep apnoea.

Guidelines for Proper Use (Pharmacist and Clinic Advice)

• Only Use as Directed: Take only as prescribed. Never share with others, even if they have similar symptoms.
• Store Safely: Keep out of sight and reach of children. Store at room temperature (<30°C), protected from moisture.
• Patient Safety: Do not combine with alcohol or illicit drugs. Do not operate machinery or drive after taking Hypnite.
• Missed Dose: Skip if you forget; do not double up to catch up.
• Stopping: Consult your doctor about tapering off the medicine to avoid withdrawal or rebound insomnia.
• Additional Support: Consider sleep hygiene practices: regular bedtimes, reducing caffeine in the evenings, limiting screen time, and establishing a relaxing routine before bed.

Alternative Treatment Options

• Benzodiazepines: Temazepam (PBS reimbursed), Diazepam — effective but higher risk of dependence and hangover symptoms.
• Melatonin: Circadin — best for people aged 55+, fewer side effects, available OTC for older adults.
• Other Z-drugs: Zolpidem (Stilnox, PBS reimbursed) — similar efficacy, but higher risk of sleepwalking/sleep activities.
• Antihistamines: (e.g., doxylamine; over-the-counter) — often sedating, but can cause drowsiness the next morning.
• Non-drug options: Cognitive behavioural therapy for insomnia (CBTI), good sleep hygiene, and mindfulness practices—strongly supported by the Australian Sleep Association as first-line treatments.

Comparison: Hypnite offers rapid onset and fewer next-day hangover symptoms than benzodiazepines, but should still be used short-term and carefully monitored.

Legal, Registration, and Reimbursement Status in Australia

• Regulatory Authority: Therapeutic Goods Administration (TGA), Australia
• Legal Status: Schedule 4 (S4) – Prescription Only Medicine
• Reimbursement: Not listed on the Pharmaceutical Benefits Scheme (PBS) as of June 2024; patients pay full private cost.
• Prescription Requirements: Prescription required from an authorised Australian medical practitioner; repeats must be justified.
• Other: Strict limits on dispensing; cannot be supplied online without a validated prescription and proper pharmacy review.

Latest Research and Clinical Guidance (2022–2025)

• Clinical guidelines affirm Cognitive Behavioural Therapy for Insomnia (CBTI) as first-line, with eszopiclone reserved for cases where non-drug therapies are inadequate or as a temporary adjunct (Australia Sleep Foundation, 2023; Sleep Health Foundation, 2024).
• Meta-analyses (e.g., J Sleep Res 2023) show eszopiclone improves sleep onset, duration, and quality versus placebo, with a smaller risk of dependence compared to benzodiazepines when used short-term.
• Recent studies recommend limiting treatment to 2–4 weeks with regular review (Therapeutic Guidelines: Psychotropic, 8th ed., 2023).
• There are stricter warnings about rare but serious sleep behaviours (e.g., sleep-driving), especially in those mixing with alcohol or other sedatives (TGA Safety Advisory, February 2024).

Availability and Delivery

• Pharmacy Collection: Available same day with valid prescription in-store.
• Online Orders: 1–3 business days, metro areas; 3–5 days for rural/regional postcodes. ID verification required for delivery.

FAQ – Frequently Asked Questions about Hypnite (Eszopiclone)

• Can I develop dependence on Hypnite?
  Prolonged or frequent use of Hypnite can lead to dependence, especially if taken for more than a few weeks. Use only as prescribed and talk to your doctor if you feel you “need” it to sleep.
• Can I drive or operate machinery after taking Hypnite?
  No. Hypnite can cause drowsiness for several hours. Do not drive, cycle, or operate heavy machinery after taking your dose until you know how it affects you, usually not until the next day.
• What if I forget to take my tablet at bedtime?
  Skip that dose and take the next one at the usual time. Do not take in the middle of the night or double up to catch up.
• Is it safe to combine Hypnite with natural sleep remedies?
  Many herbal and over-the-counter sleep aids can increase drowsiness. Always inform your doctor about all supplements or remedies you are taking.
• Will I need regular check-ups?
  Yes. Hypnite should only be continued if clinically necessary, with regular doctor reviews every 2–4 weeks to assess your progress and check for side effects.